Streamline Health Solutions Toekomstige groei
Future criteriumcontroles 1/6
De verwachting is dat Streamline Health Solutions de winst en omzet met respectievelijk 66.7% en 9.9% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 66.6% per jaar.
Belangrijke informatie
66.7%
Groei van de winst
66.6%
Groei van de winst per aandeel
| Healthcare Services winstgroei | 30.5% |
| Inkomstengroei | 9.9% |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 12 Jun 2024 |
Recente toekomstige groei-updates
Recent updates
Why Investors Shouldn't Be Surprised By Streamline Health Solutions, Inc.'s (NASDAQ:STRM) 42% Share Price Plunge
Sep 13
Streamline Health Solutions (NASDAQ:STRM) Is Making Moderate Use Of Debt
Aug 14Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Share Price Boosted 46% But Its Business Prospects Need A Lift Too
Jun 21Streamline Health Solutions, Inc. (NASDAQ:STRM) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough
May 07Revenues Working Against Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Share Price Following 26% Dive
Jan 26Revenue Downgrade: Here's What Analysts Forecast For Streamline Health Solutions, Inc. (NASDAQ:STRM)
Dec 16Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?
Dec 07Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Intrinsic Value Is Potentially 76% Above Its Share Price
Oct 04Would Streamline Health Solutions (NASDAQ:STRM) Be Better Off With Less Debt?
Sep 07There's Reason For Concern Over Streamline Health Solutions, Inc.'s (NASDAQ:STRM) Price
Jul 26Health Check: How Prudently Does Streamline Health Solutions (NASDAQ:STRM) Use Debt?
Jan 31Streamline Health GAAP EPS of -$0.07 in-line, revenue of $5.99M beats by $0.79M
Sep 07Streamline Health rallies after signing new contract with care delivery client based in Southwest
Jul 20We Think Streamline Health Solutions (NASDAQ:STRM) Has A Fair Chunk Of Debt
Jun 08Streamline Health Solutions (NASDAQ:STRM) Has Debt But No Earnings; Should You Worry?
Feb 11Need To Know: This Analyst Just Made A Substantial Cut To Their Streamline Health Solutions, Inc. (NASDAQ:STRM) Estimates
Dec 11Streamline Health Solutions, Inc. Is A Massive Medical SaaS Opportunity
Dec 03Is Streamline Health Solutions (NASDAQ:STRM) A Risky Investment?
Jul 27Streamline Health Solutions, Inc. 2021 Q1 - Results - Earnings Call Presentation
Jun 09Is Streamline Health Solutions (NASDAQ:STRM) Using Debt Sensibly?
Dec 11
Streamline Health Solutions, Inc. 2020 Q3 - Results - Earnings Call Presentation
Dec 10Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 1/31/2027 | 23 | N/A | 3 | N/A | 1 |
| 1/31/2026 | 21 | -6 | 2 | N/A | 1 |
| 1/31/2025 | 20 | -8 | -2 | N/A | 1 |
| 7/31/2024 | 20 | -19 | -3 | -2 | N/A |
| 4/30/2024 | 22 | -19 | -5 | -4 | N/A |
| 1/31/2024 | 23 | -19 | -4 | -2 | N/A |
| 10/31/2023 | 24 | -20 | -7 | -5 | N/A |
| 7/31/2023 | 24 | -11 | -7 | -5 | N/A |
| 4/30/2023 | 24 | -11 | -8 | -6 | N/A |
| 1/31/2023 | 25 | -11 | -9 | -7 | N/A |
| 10/31/2022 | 24 | -9 | -6 | -5 | N/A |
| 7/31/2022 | 23 | -10 | -7 | -5 | N/A |
| 4/30/2022 | 20 | -7 | -6 | -5 | N/A |
| 1/31/2022 | 17 | -7 | -5 | -4 | N/A |
| 10/31/2021 | 14 | -9 | -5 | -3 | N/A |
| 7/31/2021 | 11 | -5 | -4 | -3 | N/A |
| 4/30/2021 | 11 | -6 | -3 | -2 | N/A |
| 1/31/2021 | 11 | -5 | -8 | -6 | N/A |
| 10/31/2020 | 11 | -6 | -7 | -5 | N/A |
| 7/31/2020 | 12 | -1 | -7 | -4 | N/A |
| 4/30/2020 | 12 | -2 | -7 | -5 | N/A |
| 1/31/2020 | 12 | -1 | -3 | 0 | N/A |
| 10/31/2019 | 15 | -2 | -2 | 1 | N/A |
| 7/31/2019 | 16 | -6 | -2 | 1 | N/A |
| 4/30/2019 | 19 | -6 | -1 | 2 | N/A |
| 1/31/2019 | 22 | -6 | -2 | 1 | N/A |
| 10/31/2018 | 23 | -3 | 0 | 3 | N/A |
| 7/31/2018 | 24 | -2 | 1 | 3 | N/A |
| 4/30/2018 | 25 | -2 | N/A | 4 | N/A |
| 1/31/2018 | 24 | -3 | N/A | 2 | N/A |
| 10/31/2017 | 25 | -4 | N/A | 1 | N/A |
| 7/31/2017 | 25 | -6 | N/A | 0 | N/A |
| 4/30/2017 | 26 | -6 | N/A | 2 | N/A |
| 1/31/2017 | 27 | -6 | N/A | 1 | N/A |
| 10/31/2016 | 27 | -7 | N/A | 1 | N/A |
| 7/31/2016 | 28 | -6 | N/A | 5 | N/A |
| 4/30/2016 | 29 | -5 | N/A | 4 | N/A |
| 1/31/2016 | 28 | -6 | N/A | 6 | N/A |
| 10/31/2015 | 29 | -9 | N/A | 3 | N/A |
| 7/31/2015 | 28 | -11 | N/A | 2 | N/A |
| 4/30/2015 | 27 | -12 | N/A | 0 | N/A |
| 1/31/2015 | 28 | -13 | N/A | -3 | N/A |
| 10/31/2014 | 28 | -10 | N/A | -3 | N/A |
| 7/31/2014 | 27 | -14 | N/A | -3 | N/A |
| 4/30/2014 | 29 | -13 | N/A | -1 | N/A |
| 1/31/2014 | 28 | -13 | N/A | 0 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachting is dat STRM de komende 3 jaar verliesgevend zal blijven.
Winst versus markt: De verwachting is dat STRM de komende 3 jaar verliesgevend zal blijven.
Hoge groeiwinsten: De verwachting is dat STRM de komende 3 jaar verliesgevend zal blijven.
Omzet versus markt: De omzet van STRM ( 9.9% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.8% per jaar).
Hoge groei-inkomsten: De omzet van STRM ( 9.9% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van STRM naar verwachting over 3 jaar hoog zal zijn